NursingPlex
    Sign In
    Ati Lpn 112 Med Surg Final Proctored Exam

    A nurse is caring for a newborn who was born at 37 weeks of gestation and is 12 hours old. Complete the diagram by dragging from the choices below to specify what condition the newborn is most likely experiencing, 2 actions the nurse should take to address that condition, and 2 parameters the nurse should monitor to assess the newborn's progress.

    Explanation & Rationale

    Rationale for correct condition Respiratory distress syndrome is caused by a deficiency in pulmonary surfactant, which increases alveolar surface tension and leads to atelectasis. The newborn displays classic clinical manifestations including tachypnea (90/min), grunting, nasal flaring, and substernal retractions. These signs indicate significant work of breathing and impaired gas exchange. The newborn was born at 37 weeks, which is early term, but may still lack adequate surfactant production. Alveolar collapse during expiration leads to decreased functional residual capacity and hypoxia. Grunting is an expiratory effort to maintain positive end-expiratory pressure and prevent alveolar closure. The presence of substernal retractions indicates the use of accessory muscles to overcome lung stiffness. This condition explains the oxygen saturation of 92% and the compensatory respiratory effort noted in the notes. Rationale for correct actions Immediate interventions focus on optimizing oxygenation and addressing the underlying pathophysiology of surfactant deficiency. Providing supplemental oxygen ensures adequate tissue perfusion and prevents cellular hypoxia. Exogenous surfactant administration reduces surface tension within the alveoli, improving lung compliance and decreasing the overall work of breathing. Oxygen administration should be titrated to maintain saturation levels within the target neonatal range of 90% to 95%. This prevents the complications of both hypoxia and hyperoxia, such as retinopathy of prematurity. Surfactant is typically administered via an endotracheal tube to stabilize the alveolar-capillary membrane. This treatment directly targets the primary cause of respiratory distress syndrome in the newborn. Stabilizing the lungs reduces the risk of long-term pulmonary complications and mechanical ventilation dependency. Rationale for correct parameters Monitoring focuses on the adequacy of gas exchange and the newborn's response to respiratory support. Arterial blood gases provide precise data on acid-base balance and the partial pressures of oxygen and carbon dioxide. Continuous oxygen saturation monitoring allows for real-time assessment of arterial hemoglobin saturation and guides titration of oxygen therapy. Arterial blood gases (normal: ph 7.32 to 7.45) must be monitored to detect worsening respiratory acidosis or metabolic compensation. The current ph of 7.30 indicates a slight acidemia that requires close observation as the infant tires. Oxygen saturation (normal: >90% for term/near-term) is a non-invasive parameter used to detect sudden clinical deterioration. Falling saturation levels may indicate the need for increased positive pressure or surfactant replacement. These two parameters together offer a comprehensive view of the newborn's respiratory and metabolic status. Rationale for incorrect conditions Hyperbilirubinemia is incorrect as the bilirubin level of 4 mg/dl is well within the normal range of 1.0 to 12.0 mg/dl. Hypoglycemia is ruled out because the blood glucose of 40 mg/dl is within the normal neonatal range of 30 to 60 mg/dl. Neonatal abstinence syndrome typically presents with central nervous system irritability and gastrointestinal dysfunction, which are not present here. Hyperbilirubinemia would manifest as jaundice and does not typically cause acute respiratory distress or retractions. Hypoglycemia often presents with jitteriness, lethargy, or a high-pitched cry, rather than isolated respiratory grunting. The newborn's glucose level is currently stable and does not require acute intervention. Neonatal abstinence syndrome occurs following intrauterine drug exposure and is characterized by tremors and poor feeding. This client's symptoms are strictly localized to the respiratory system and work of breathing. Rationale for incorrect actions Bottle feeding formula is contraindicated in a newborn with a respiratory rate of 90/min due to the high risk of aspiration. A urine toxicology screen is only indicated if neonatal abstinence syndrome is suspected based on maternal history or newborn behavior. Phototherapy is the treatment for hyperbilirubinemia, which this infant does not have based on a normal bilirubin level. Feeding an infant with tachypnea (>60/min) significantly increases the risk of inhaling liquid into the lungs. Urine toxicology does not address the immediate life-threatening nature of the newborn's respiratory distress. Phototherapy treats elevated bilirubin levels by converting unconjugated bilirubin into a water-soluble form. It has no therapeutic effect on lung compliance or surfactant deficiency. These actions do not align with the physiological priorities of a newborn in respiratory failure. Rationale for incorrect parameters Blood glucose level monitoring is important for all newborns but is not the primary parameter for assessing progress in respiratory distress. Bilirubin level monitoring is unnecessary as the initial value was normal and the client lacks signs of jaundice. Signs of overstimulation are monitored in neonatal abstinence syndrome to guide environmental modifications and swaddling. The glucose level of 40 mg/dl is currently adequate and does not explain the tachypnea or grunting. While bilirubin may rise later, it is not a parameter used to evaluate the success of surfactant therapy. Overstimulation assessments are used for infants with neurologic irritability, not those with primary pulmonary pathology. These parameters would fail to provide the nurse with data regarding the infant's oxygenation or ventilatory efficiency. Therefore, they are secondary to the assessment of blood gases and oxygen saturation. Test-taking strategy Analyze vital signs first: Recognize that a respiratory rate of 90/min is dangerously high (tachypnea) and the saturation is at the lower limit of normal. Identify the physiological priority: The presence of grunting, flaring, and retractions signals respiratory distress, which takes priority over other metabolic concerns. Utilize lab data: Confirm that the glucose and bilirubin are within normal ranges, allowing you to rule out hypoglycemia and hyperbilirubinemia. Assess gestational age: A newborn at 37 weeks is "early term" and can still experience surfactant deficiency, which is the hallmark of respiratory distress syndrome. Priority of care: Follow the abcs (airway, breathing, circulation). Respiratory support through oxygen and surfactant is the most life-saving intervention for this clinical picture. Take home points Respiratory distress syndrome is characterized by surfactant deficiency, leading to high alveolar surface tension and atelectasis. Grunting is a compensatory mechanism used by the newborn to increase end-expiratory pressure and keep alveoli open. Newborns with a respiratory rate greater than 60/min should be kept NPO (nothing by mouth) to prevent aspiration pneumonia. Surfactant administration and oxygen therapy are the primary medical interventions to improve lung compliance and gas exchange.

    🔒 Submit your answer to reveal
    📋 View Case Study